Abstract:Amyloids are insoluble fibrillar protein aggregates. While they are commonly found in human diseases, it is becoming increasingly clear that this type of structure is essential for a range of biological functions, with prominent examples in organisms ranging from bacteria to human. Functional amyloid and pathogenic amyloid share similar physical and chemical properties. Unlike pathological amyloids, however, the structures of functional amyloids are formed by polypeptide sequences whose amyloid structure has been under a positive evolutionary selection pressure. This important distinction provides us with an opportunity to obtain structural insights from an unexpected source: the covariation of amino acids among sequences within the same family of a functional amyloid protein. There is a long history for the idea of using coevolution for molecular structure prediction, but recent growth in sequence databases and new, efficient algorithms to disentangle indirect couplings in a network, have dramatically improved our ability to predict residue-residue contacts. We used recently developed sequence analysis methods (EVcoupling, PSICOV and GREMLIN) to extract distance restraints from a multiple sequence alignment of a functional amyloid protein. Together with an efficient force field, these restraints allow us to determine atomic resolution structural models. We find that the protein forms a beta-helical structure, where each turn corresponds to previously identified repeat sequences. The proposed structure is validated by previously published solid-state NMR, electron microscopy and X-ray diffraction data, and confirms an earlier proposed model derived by complementary means. To our knowledge, this is the first time the analysis of correlated mutations and computer simulations have been used together to study the structure of a functional amyloid. The current study therefore serves as a probe into the potential applicability of the approach in this domain.

Distinguishing the cross-β spine arrangements in amyloid fibrils using FRET analysis

Identification of a Novel Parallel Β‐strand Conformation Within Molecular Monolayer of Amyloid Peptide

The common architecture of cross-beta amyloid

Analysis of XFEL serial diffraction data from individual crystalline fibrils

Conformational Dynamics of an α-Synuclein Fibril upon Receptor Binding Revealed by Insensitive Nuclei Enhanced by Polarization Transfer-Based Solid-State Nuclear Magnetic Resonance and Cryo-Electron Microscopy

What Does Evolution Tell Us About The Structure Of A Functional Amyloid Protein?

Structure of a Functional Amyloid Protein Subunit Computed Using Sequence Variation.

Structural mechanism for specific binding of chemical compounds to amyloid fibrils

Competition between crystal and fibril formation in molecular mutations of amyloidogenic peptides

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Structural Evaluation of an Amyloid Fibril Model Using Small-Angle X-Ray Scattering

In cell NMR reveals cells selectively amplify and structurally remodel amyloid fibrils

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

Cross-Reactive Fluorescent Sensor Array for Discrimination of Amyloid Beta Aggregates

Structural characterization of amyloid aggregates with spatially resolved infrared spectroscopy

Amyloid β 42 fibril structure based on small-angle scattering

Subtle change of fibrillation condition leads to substantial alteration of recombinant Tau fibril structure

Live Cell FRET Imaging Reveals Amyloid β-Peptide Oligomerization in Hippocampal Neurons

Deciphering the Morphological Difference of Amyloid-β Fibrils in Familial and Sporadic Alzheimer’s Diseases

Nanomechanics of Amyloid Materials Studied by Atomic Force Microscopy

High resolution spectroscopy reveals fibrillation inhibition pathways of insulin